Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recent advances in the management of lung cancer.

Literature DB >> 29700092

Recent advances in the management of lung cancer.

Abstract

Historically, the prognosis for individuals diagnosed with lung cancer has been bleak. However, the past 10 years have seen important advances in treatment and diagnosis which have translated into the first improvements seen in lung cancer survival. This review highlights the major advances in treatments with curative intent, systemic targeted therapies, palliative care and early diagnosis in lung cancer. We discuss the pivotal research that underpins these new technologies/strategies and their current position in clinical practice. © Royal College of Physicians 2018. All rights reserved.

Entities: Disease Species

Keywords: Lung cancer; curative treatment; early diagnosis; lung cancer management; targeted therapies

Mesh：

Year: 2018 PMID： 29700092 PMCID： PMC6334032 DOI： 10.7861/clinmedicine.18-2-s41

Source DB: PubMed Journal: Clin Med (Lond) ISSN： 1470-2118 Impact factor: 2.659

32 in total

1. Percutaneous radiofrequency ablation of malignancies in the lung.

Authors: D E Dupuy; R J Zagoria; W Akerley; W W Mayo-Smith; P V Kavanagh; H Safran
Journal: AJR Am J Roentgenol Date: 2000-01 Impact factor: 3.959

2. Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors: Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal: JAMA Date: 2010-03-17 Impact factor: 56.272

3. Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245

Review 4. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update.

Authors: Betty R Ferrell; Jennifer S Temel; Sarah Temin; Erin R Alesi; Tracy A Balboni; Ethan M Basch; Janice I Firn; Judith A Paice; Jeffrey M Peppercorn; Tanyanika Phillips; Ellen L Stovall; Camilla Zimmermann; Thomas J Smith
Journal: J Clin Oncol Date: 2016-10-28 Impact factor: 44.544

5. Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial.

Authors: Marie A Bakitas; Tor D Tosteson; Zhigang Li; Kathleen D Lyons; Jay G Hull; Zhongze Li; J Nicholas Dionne-Odom; Jennifer Frost; Konstantin H Dragnev; Mark T Hegel; Andres Azuero; Tim A Ahles
Journal: J Clin Oncol Date: 2015-03-23 Impact factor: 44.544

6. Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database.

Authors: Pierre-Emmanuel Falcoz; Marc Puyraveau; Pascal-Alexandre Thomas; Herbert Decaluwe; Martin Hürtgen; René Horsleben Petersen; Henrik Hansen; Alessandro Brunelli
Journal: Eur J Cardiothorac Surg Date: 2015-04-26 Impact factor: 4.191

7. Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit.

Authors: Helen A Powell; Laila J Tata; David R Baldwin; Rosamund A Stanley; Aamir Khakwani; Richard B Hubbard
Journal: Thorax Date: 2013-05-17 Impact factor: 9.139

8. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.

Authors: Scott J Antonia; José A López-Martin; Johanna Bendell; Patrick A Ott; Matthew Taylor; Joseph Paul Eder; Dirk Jäger; M Catherine Pietanza; Dung T Le; Filippo de Braud; Michael A Morse; Paolo A Ascierto; Leora Horn; Asim Amin; Rathi N Pillai; Jeffry Evans; Ian Chau; Petri Bono; Akin Atmaca; Padmanee Sharma; Christopher T Harbison; Chen-Sheng Lin; Olaf Christensen; Emiliano Calvo
Journal: Lancet Oncol Date: 2016-06-04 Impact factor: 41.316

9. Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer?

Authors: Frank J Lagerwaard; Suresh Senan; Jan P van Meerbeeck; Wilfried J Graveland
Journal: Radiother Oncol Date: 2002-05 Impact factor: 6.280

10. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Authors: J K Field; S W Duffy; D R Baldwin; D K Whynes; A Devaraj; K E Brain; T Eisen; J Gosney; B A Green; J A Holemans; T Kavanagh; K M Kerr; M Ledson; K J Lifford; F E McRonald; A Nair; R D Page; M K B Parmar; D M Rassl; R C Rintoul; N J Screaton; N J Wald; D Weller; P R Williamson; G Yadegarfar; D M Hansell
Journal: Thorax Date: 2015-12-08 Impact factor: 9.139

83 in total

1. Epidemiologic study of epidural analgesia for lung cancer surgery from 2011 to 2018 in South Korea: a National Health Insurance Database cohort study.

Authors: Tak Kyu Oh; In-Ae Song
Journal: Korean J Anesthesiol Date: 2022-07-15

2. Effect of intercostal nerve block combined with oxycodone on the postoperative cognitive ability in elderly patients undergoing radical resection of lung cancer.

Authors: Qiang Wang; Jiao Guo; Minna Hou
Journal: Am J Transl Res Date: 2022-09-15 Impact factor: 3.940

3. Origin recognition complex 1 regulates phospholipase Cδ1 to inhibit cell proliferation, migration and epithelial-mesenchymal transition in lung adenocarcinoma.

Authors: Yao Jian; Qing Qiao; Juanjuan Tang; Xiaobing Qin
Journal: Oncol Lett Date: 2022-06-10 Impact factor: 3.111

4. Effect of Thymosin on Inflammatory Factor Levels, Immune Function, and Quality of Life in Lung Cancer Patients Undergoing Radical Thoracoscopic Surgery.

Authors: Junjie Zhao; Niu Niu; Zhengfu He
Journal: Evid Based Complement Alternat Med Date: 2022-07-04 Impact factor: 2.650

5. Ex Vivo Irradiation of Lung Cancer Stem Cells Identifies the Lowest Therapeutic Dose Needed for Tumor Growth Arrest and Mass Reduction In Vivo.

Authors: Caterina Puglisi; Raffaella Giuffrida; Giuseppina Borzì; Salvatore Illari; Francesco Paolo Caronia; Paolo Di Mattia; Cristina Colarossi; Gianluca Ferini; Emanuele Martorana; Giovanni Sette; Adriana Eramo; Aurelio Lorico; Alfio Di Grazia; Stefano Forte
Journal: Front Oncol Date: 2022-05-12 Impact factor: 5.738

6. Antiproliferative and Proapoptotic Effects of Phenanthrene Derivatives Isolated from Bletilla striata on A549 Lung Cancer Cells.

Authors: Fei Zhou; Rui Feng; Ou Dai; Lian Yang; Yu Liu; Yun-Cai Tian; Cheng Peng; Liang Xiong
Journal: Molecules Date: 2022-05-30 Impact factor: 4.927

7. Clinical and Computed Tomography Characteristics of Solitary Pulmonary Nodules Caused by Fungi: A Comparative Study.

Authors: Jin Jiang; Zhuo-Ma Lv; Fa-Jin Lv; Bin-Jie Fu; Zhang-Rui Liang; Zhi-Gang Chu
Journal: Infect Drug Resist Date: 2022-10-18 Impact factor: 4.177

8. Lidocaine represses the malignant behavior of lung carcinoma cells via the circ_PDZD8/miR-516b-5p/GOLT1A axis.

Authors: Huafen Zi; Li Chen; Qian Ruan
Journal: Histol Histopathol Date: 2022-01-21 Impact factor: 2.303

9. Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells.

Authors: Jinyuan Liu; Chunfeng Pan; Rongxin Lu; Shijiang Zhang
Journal: Bioengineered Date: 2022-03 Impact factor: 6.832

10. Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway.

Authors: Rujian Lu; Qian Zhou; Linling Ju; Lin Chen; Feng Wang; Jianguo Shao
Journal: Oncol Rep Date: 2021-06-29 Impact factor: 3.906